| Thomas J Tavenner, CRNA | |
|
1000 N Main St, Richfield, UT 84701-1857 | |
| (435) 893-4100 | |
| Not Available |
| Full Name | Thomas J Tavenner |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1000 N Main St, Richfield, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912002536 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 149511205797 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas J Tavenner, CRNA 1105 N 500 E, Richfield, UT 84701-1917 Ph: (435) 896-2934 | Thomas J Tavenner, CRNA 1000 N Main St, Richfield, UT 84701-1857 Ph: (435) 893-4100 |
News Archive
The Rhode Island House Committee on Health, Education and Welfare last week held a hearing on a proposed amendment to a state requirement that physicians obtain written consent before administering an HIV test, the Providence Journal reports.
Teva Pharmaceutical Industries Ltd. today announced results from the placebo group analyses of the ADAGIO study that were presented at the 62nd Annual Meeting of the American Academy of Neurology. The ADAGIO study stands out from other Parkinson's disease trials as it is the largest clinical study conducted in patients who were still in the very early stages of their disease course (average time from PD diagnosis of 4.5 months).
Almost 1 in 20 women who gives birth will go on to develop thyroid problems within two years, according to a new study presented at the European Congress of Endocrinology in Rotterdam. This could have significant implications for the future health of the mother and child, as well as potentially presenting problems for future pregnancies.
The big noise on the health insurance front today was sounded by Target, which announced via a corporate blog that it's ending health insurance for its part-time workers. Instead of signing up for a company plan, they're encouraged to use the health care exchanges set up through the Affordable Care Act. ...
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its U.S. Patent Application Number 11/226,908 entitled "Methods for Treatment with Bucindolol Based on Genetic Targeting." The Notice of Allowance is the USPTO's official communication that the examination of the patent application has been successfully completed and that a patent will be issued.
› Verified 9 days ago
Elosia Furbee, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1000 N Main St, Richfield, UT 84701 Phone: 435-893-4100 | |
Rex K Belnap, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1000 N Main St, Richfield, UT 84701 Phone: 435-893-0305 Fax: 435-893-0369 | |
Robert Dustin Bulloch, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1000 N Main St, Richfield, UT 84701 Phone: 435-893-4100 |